News

Simulmedia Welcomes Jonathan Steuer as Chief Scientist

Simulmedia Welcomes Jonathan Steuer as Chief Scientist

Simulmedia Appoints Jonathan Steuer as Chief Scientist

Simulmedia, a leader in cross-channel TV and connected TV (CTV) advertising, is thrilled to announce a significant addition to its executive team. Jonathan Steuer, a prominent figure in media research and data science, has been appointed as the Chief Scientist. With a remarkable background as a scientist and innovator, Steuer is set to play a crucial role in enhancing Simulmedia's mission to transform the future of TV and CTV advertising.

Jonathan Steuer's Vision and Role

As Chief Scientist, Steuer will report directly to CEO Dave Morgan and will be instrumental in shaping the company's scientific vision and strategy. His leadership is expected to steer Simulmedia to the forefront of advancements in machine learning and AI within the advertising realm. By collaborating closely with the Product, Engineering, and Data Science teams, Steuer will ensure that data-driven best practices are woven into every aspect of Simulmedia’s offerings, including its flagship products, TV+, Skybeam, and PlayerWON.

Steuer's Expertise and Past Achievements

Jonathan Steuer has a rich history within the advertising industry, with experience in various leadership positions at major organizations. Previously, he served as Chief Research Officer at Omnicom Media Group, where he played a key role in developing advanced TV measurement methodologies. His expertise in delivering data-driven strategies for some of the world's largest advertisers highlights his capability and vision.

Contributions to the Industry

Most recently, Steuer contributed as EVP of TV Strategy and Currency at VideoAmp, where he championed new audience measurement standards and alternative media currency solutions. His commitment to pushing industry boundaries will undoubtedly benefit Simulmedia as it continues to innovate.

Research Papers and Insights

Recently, Steuer co-authored significant research for a leading industry organization on the US media and measurement ecosystem. His work outlines the evolving landscape of TV measurement and emphasizes the importance of panel-based measurement solutions. This research not only reflects his deep understanding of market dynamics but also his vision for advancing measurement processes across various platforms.

Innovations in Audience Measurement

Before his tenure at VideoAmp, Steuer was Chief Research Officer at TiVo, where he pioneered methodologies for measuring audience engagement and time-shifted viewing. With his deep-rooted academic expertise, including a Ph.D. in Communication Theory and Research from Stanford University, Steuer is well-equipped to lead the charge in audience measurement and optimizing advertising campaigns.

Steuer's Vision for Simulmedia

In his own words, Steuer expresses excitement about addressing challenges in TV and CTV advertising. He emphasizes the need for transparency and innovation, which are key tenets of Simulmedia’s philosophy. His focus will not only enhance the understanding of audience metrics but also improve the overall advertising experience.

Future Collaborations and Leadership

Steuer will also mentor Simulmedia’s Data Science team, encouraging a culture of creativity and innovation. Representing the company at industry events and trade organizations, Steuer will fortify Simulmedia’s reputation as a thought leader in advertising technology. His collaboration with top executives will be pivotal in driving the company’s intellectual property strategy, safeguarding its innovative services.

About Simulmedia

Simulmedia stands at the forefront of cross-channel TV and CTV advertising solutions, empowering brands and agencies to execute highly effective campaigns. With cutting-edge products like TV+, Skybeam, and PlayerWON, Simulmedia leverages advanced analytics to reshape the advertising landscape, ensuring that clients achieve exceptional outcomes.

Frequently Asked Questions

What is Jonathan Steuer's role at Simulmedia?

Jonathan Steuer is the Chief Scientist at Simulmedia, responsible for guiding scientific strategy and innovation in advertising.

What are Simulmedia's key products?

Simulmedia's flagship products include TV+, Skybeam, and PlayerWON, designed to enhance cross-channel advertising effectiveness.

How has Steuer contributed to the industry?

Steuer has led initiatives in TV measurement and audience metrics throughout his career, including roles at Omnicom Media Group and VideoAmp.

What is the focus of Steuer's research?

Steuer's research emphasizes evolving measurement practices and the importance of data integrity in advertiser strategies.

What will Steuer's leadership mean for Simulmedia?

His leadership is expected to foster innovation, enhance audience understanding, and solidify Simulmedia’s position as a leader in advertising technology.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

ON1 Photo RAW 2027: New AI Tools, Better Processing

Updated Category News Views 50

Aiming for the Photography Crown ON1 isn't just tinkering on the fringes with their new Photo RAW 2027 release—they're diving headfirst into the deep end, aiming to outdo giants in the RAW processing world. I've seen my share of software updates that don't move the needle, but this one's packed to the gills with updates that photographers have been clamoring for. What's...

Continue Reading
China's Innovation Surge: Game Changer for Global Markets

Updated Category News Views 235

The Bold Shift in China's Economic Landscape Well, here's the scoop: China isn't just the world's assembly line anymore; it's gearing up to be a top-tier innovation hub. On the surface, might seem like another geopolitical spiel, but dig a little and you'll find it's a serious shake-up for global markets. We're talking about more than just products rolling out of...

Continue Reading
Jeep Wrangler Scrambler SRT: A Bold Off-Road Rebirth

Updated Category News Views 0

A New Legend in the Making Who would've thought we'd see the day when an SRT badge graced a Jeep Wrangler with such audacity? This ain't your typical Wrangler—they’ve slapped a bit of that CJ-8 throwback swagger, and given it the full-on SRT treatment. It's a mad machine, barreling into the future with one foot firmly planted in its legendary past. You ask any...

Continue Reading
Florida Homebuyers: Navigating Flood Zone Risks Smartly

Updated Category News Views 92

Florida Properties: The Buried Risk in Flood Zones If you’re dreaming of palm trees and sandy beaches, don't let flood zones turn that dream into a nightmare. It’s not all sunshine and rainbows when it comes to buying real estate in Florida, as it turns out—flood zones are lurking, and the devil's in the details. Understanding FEMA Flood Maps First off, these FEMA...

Continue Reading
ACA 2027 Enrollment: New Rules Aim to Simplify Coverage

Updated Category News Views 61

Navigating New Waters in 2027 ACA Open Enrollment If you're one of those folks who likes to wait until the last minute, the ACA's got a wake-up call for you this year. The 2027 open enrollment period started on November 1, 2026, with some pretty notable changes. The deadline for coverage beginning January 1, 2027, is December 15, so don't take a nap on this one, alright?...

Continue Reading
Beyon Expands Green Data Centres to Three Facilities

Updated Category News Views 37

Blazing Solar Trails in the Digital Landscape Lend an ear, folks, because Beyon's latest leap in the world of renewable energy isn't just another 'look how green we are' maneuver. Announced during Gateway Gulf 2026, this venture is all about serious numbers and even more serious energy chops. Beyon's on course to power a third data center entirely through solar energy,...

Continue Reading
Lazard Closes Deal with Campbell, Launches Lazard CL

Updated Category News Views 59

Talk about pulling a rabbit out of the hat! Lazard has just solidified its position in the private capital advisory game with the closure of its acquisition of Campbell Lutyens. They’re now rolling out Lazard CL, merging muscle across different strategies and diversifying those good ol’ revenue streams. It’s a peppy move from Lazard—not just for the cold hard...

Continue Reading
Xylitol: A Game Changer in Kids' Oral Care Battle

Updated Category News Views 91

Candy Challenges: Embracing Sweet Joys Responsibly Think you're done with Halloween? Nope. Welcome to the endless candy seasons when every festivity seems like an outlet for sugar overload—with parents caught between letting kids enjoy and guarding their teeth. Now, with Spry's recent push around xylitol, there's an option that might just mean an easier peace between...

Continue Reading
Military Medical Minds to Converge at MTEC Event in 2027

Updated Category News Views 72

Ever wonder where the cutting edge of military medicine takes shape? On February 16-17, 2027, Washington, DC becomes the epicenter for just that, as the Medical Technology Enterprise Consortium (MTEC) rolls out its 11th Annual Membership Meeting. A gathering of who's who in the world of military medical innovation, this event is like a high-stakes cocktail of science,...

Continue Reading
Sirolimus-Coated Balloon Shows Promise in TRANSFORM II

Updated Category News Views 96

Breaking Down the TRANSFORM II Trial Innovation never rests, folks, especially when it comes to treating coronary artery disease. Right on cue, the TRANSFORM II trial's results have hit the airwaves, marking a significant milestone with its implant-free MagicTouch Sirolimus-Coated Balloon (SCB) strategy. Getting the Lay of the Land This wasn't just some backyard...

Continue Reading

Top 5 Most Recently Viewed Articles

ATYR Stock Investors: Important Class Action Update

Updated Category News Views 139

Key Information for ATYR Pharma Shareholders ATYR Pharma, Inc. has recently faced significant challenges that have caught the attention of its shareholders. Investors who have purchased shares of ATYR during the specified class period are encouraged to stay informed about the ongoing legal developments. Engaging with The Gross Law Firm can provide shareholders with the...

Continue Reading
Zymeworks Stock Target Steady After Positive Trial Results

Updated Category News Views 89

Zymeworks Keeps Stock Rating Steady After ESMO 2024 Results Zymeworks Inc. (NASDAQ: ZYME) has maintained its stock rating and price target after revealing encouraging results from its recent cancer treatment clinical trials at a significant medical conference. The ratings firm H.C. Wainwright has reiterated a Neutral rating and set a price target of $10.00 per share...

Continue Reading
Exploring New Opportunities in Convertible Bonds with BMAX ETF

Updated Category News Views 253

Introduction to the New ETF A recently introduced exchange-traded fund (ETF), known as the REX Bitcoin Corporate Treasury Convertible Bond ETF (BMAX), is gaining attention for its focus on convertible bonds from companies that have Bitcoin included in their financial strategies. This ETF began trading recently and represents a growing trend in the investment landscape....

Continue Reading
iBio Secures Strategic Investments to Propel Biotech Advancements

Updated Category News Views 140

iBio's Strategic Investment Announcement iBio, Inc. (NYSE: IBIO), a pioneer in AI-driven antibody immunotherapies, has made an impactful stride in its mission, announcing the successful closure of a private investment offering totaling over $650,000 from its Board of Directors and corporate officers. This investment is a significant vote of confidence in iBio's strategy...

Continue Reading
Simulmedia Welcomes Jonathan Steuer as Chief Scientist

Updated Category News Views 111

Simulmedia Appoints Jonathan Steuer as Chief Scientist Simulmedia, a leader in cross-channel TV and connected TV (CTV) advertising, is thrilled to announce a significant addition to its executive team. Jonathan Steuer, a prominent figure in media research and data science, has been appointed as the Chief Scientist. With a remarkable background as a scientist and...

Continue Reading